These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence. Teschke R; Qiu SX; Xuan TD; Lebot V Phytother Res; 2011 Sep; 25(9):1263-74. PubMed ID: 21442674 [TBL] [Abstract][Full Text] [Related]
7. Kava hepatotoxicity: a European view. Teschke R; Schwarzenboeck A; Akinci A N Z Med J; 2008 Oct; 121(1283):90-8. PubMed ID: 18841189 [TBL] [Abstract][Full Text] [Related]
8. Kava hepatotoxicity solution: A six-point plan for new kava standardization. Teschke R; Sarris J; Lebot V Phytomedicine; 2011 Jan; 18(2-3):96-103. PubMed ID: 21112196 [TBL] [Abstract][Full Text] [Related]
9. [Kava, kavapyrones and toxic liver injury]. Teschke R Z Gastroenterol; 2003 May; 41(5):395-404. PubMed ID: 12772052 [TBL] [Abstract][Full Text] [Related]
10. Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited. Teschke R; Sarris J; Schweitzer I Br J Clin Pharmacol; 2012 Feb; 73(2):170-4. PubMed ID: 21801196 [TBL] [Abstract][Full Text] [Related]
11. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate? Teschke R; Wolff A Regul Toxicol Pharmacol; 2011 Feb; 59(1):1-7. PubMed ID: 20854865 [TBL] [Abstract][Full Text] [Related]
12. Contaminant hepatotoxins as culprits for kava hepatotoxicity--fact or fiction? Teschke R; Sarris J; Lebot V Phytother Res; 2013 Mar; 27(3):472-4. PubMed ID: 22585547 [TBL] [Abstract][Full Text] [Related]
13. Liver transplantation and the use of KAVA: Case report. Becker MW; Lourençone EMS; De Mello AF; Branco A; Filho EMR; Blatt CR; Mallmann CA; Schneider M; Caregnato RCA; Blatt CR Phytomedicine; 2019 Mar; 56():21-26. PubMed ID: 30668342 [TBL] [Abstract][Full Text] [Related]